1. Home
  2. USFD vs MRNA Comparison

USFD vs MRNA Comparison

Compare USFD & MRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo US Foods Holding Corp.

USFD

US Foods Holding Corp.

HOLD

Current Price

$90.99

Market Cap

19.7B

ML Signal

HOLD

Logo Moderna Inc.

MRNA

Moderna Inc.

HOLD

Current Price

$50.96

Market Cap

19.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USFD
MRNA
Founded
2007
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Food Distributors
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
19.7B
19.7B
IPO Year
2016
2018

Fundamental Metrics

Financial Performance
Metric
USFD
MRNA
Price
$90.99
$50.96
Analyst Decision
Buy
Hold
Analyst Count
11
12
Target Price
$103.64
$34.27
AVG Volume (30 Days)
2.3M
5.3M
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
45.54
21.77
EPS
2.94
N/A
Revenue
$39,424,000,000.00
$19,263,000,000.00
Revenue This Year
$7.63
$8.74
Revenue Next Year
$3.92
$16.18
P/E Ratio
$31.33
N/A
Revenue Growth
4.08
4.29
52 Week Low
$60.46
$22.28
52 Week High
$102.13
$59.55

Technical Indicators

Market Signals
Indicator
USFD
MRNA
Relative Strength Index (RSI) 49.40 50.91
Support Level $87.44 $47.61
Resistance Level $94.27 $54.94
Average True Range (ATR) 2.30 2.53
MACD 0.00 -0.21
Stochastic Oscillator 47.67 50.66

Price Performance

Historical Comparison
USFD
MRNA

About USFD US Foods Holding Corp.

US Foods Holding Corp is a U.S. food service distributor that distributes food and nonfood products to the healthcare and hospitality industries, restaurants, education, government facilities, and grocers. It has various customer locations across the United States, with a vast network of distribution facilities, a fleet of trucks, and cash and carry locations offering food and non-food products, and a comprehensive suite of e-commerce, technology, and business solutions to its customers. The company operates in one business segment in which it markets, sells, and distributes fresh, frozen, and dry food and non-food products to foodservice customers throughout the U.S. The products offered are as snacks, beverages, fresh produce, sauces, condiments, canned/frozen fruits and others.

About MRNA Moderna Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Share on Social Networks: